IL17A and pulmonary fibrosis: Furthermore, IL-17A has been implicated in promoting alveolar epithelial cell apoptosis and exacerbating the progression of pulmonary fibrosis, disrupting normal alveolar architecture and impairing alveolar–capillary gas exchange.